| Value | ₹0.11 Cr |
|---|
BSE filing, NSE: DCMSIL. Summary written from the filing by ALFA Finder's alert engine.
DCM Shriram International Ltd: key numbers
- Share price
- ₹66.18
- Market cap
- ₹575.7 Cr
- Revenue (annual)
- ₹451.2 Cr
- Net profit (annual)
- ₹-13.78 Cr
- P/E (TTM)
- -34.0×Sector 51.7×
- Promoter holding
- 50.11%+0.00% QoQ
- FII holding
- 1.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from DCM Shriram International Ltd
All →DCM Shriram International Other Announcement
The company filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulations.
DCM Shriram International Promoter Selling (Off-Market)
Akshay Foundation disposed of 29,76,389 shares (3.42%) in DCM Shriram International Ltd via an off-market inter-se promoter transfer. The transaction was executed on September 29, 2026.
DCM Shriram International Promoter Buying (Off-Market)
Bansuri Charitable Society acquired 29,76,389 equity shares (3.42%) of DCM Shriram International Ltd. The transaction was an off-market inter-se transfer within the promoter group.
- Promoter stake change
- +3.42%
DCM Shriram International Legal & Regulatory
DCM Shriram International paid Rs. 1.94 Lakh in total fines to BSE and NSE for delayed compliance with Regulation 17(1A). The matter is now concluded.
- Value
- ₹0.02 Cr
DCM Shriram International Legal & Regulatory
DCM Shriram International Limited received a fine of ₹0.01 Crore from BSE and NSE for delayed compliance with Regulation 17(1A) of SEBI LODR Regulations.
- Value
- ₹0.01 Cr
DCM Shriram International Q1 FY27 Results: Net Profit ₹0 Cr
DCM Shriram International Ltd reported revenue from operations of ₹108.6 Cr (-4.9% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.